Regional chemotherapy: a new combined modality approach

P. E. van Schil (Edegem, Belgium)

Source: Annual Congress 2004 - Lung metastases

Session: Lung metastases
Session type: Major Symposium
Number: 1282

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. E. van Schil (Edegem, Belgium). Regional chemotherapy: a new combined modality approach. Annual Congress 2004 - Lung metastases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

A new definition of multimodality treatment Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts Year: 2016
From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017
Surgery as the best option in the multimodal treatment Source: Annual Congress 2013 –The management of N2 disease in non-small cell lung cancer Year: 2013
Combined modality treatment for NSCLC Source: Annual Congress 2007 - PG7 - Thoracic oncology: nonsmall cell lung cancer Year: 2007
Multimodal therapy in mesothelioma: which modalities are available and useful and how to combine them Source: International Congress 2014 – Mesothelioma: a never-ending story Year: 2014
Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis Source: Annual Congress 2007 - Controversies in surgical oncology Year: 2007
Concomitant radiotherapy and targeted therapies Source: International Congress 2019 – New perspectives in thoracic surgical oncology Year: 2019
Combined endoscopic evaluation of the effectiveness of neoadjuvant chemotherapy of NSCLC using autofluorescence and spectroscopic methods Source: Annual Congress 2011 - The basic and the future: pure diagnostic or dedicated wavelengths play Year: 2011
Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Modern radiotherapy as a curative treatment modality for stage III NSCLC Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease Year: 2019